First-Time Prescribing of GLP-1 Receptor Agonists from 2018-2023: A Descriptive Analysis https://www.medrxiv.org/content/10.1101/2023.08.22.23294277
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.